Works matching AU Yarchoan, Mark

Results: 35

Entinostat in combination with nivolumab for patients with advanced cholangiocarcinoma: a phase 2 clinical trial.

Published in:

Epigenetics Communications, 2025, v. 5, n. 1, p. 1, doi. 10.1186/s43682-025-00037-z

By:

Hallab, Elsa;
Durham, Jennifer N.;
Walker, Rosalind;
Cope, Leslie;
Charmsaz, Soren;
Gross, Nicole E.;
Sidiropoulos, Dimitrios N.;
Hernandez, Alexei;
Leatherman, James;
Mitchell, Sarah;
Yarchoan, Mark;
Ho, Won Jin;
Azad, Nilofer S.;
Baretti, Marina

Publication type:

Article

Successful Treatment of Neoplastic Fever with Oxybutynin.

Published in:

Journal of Palliative Medicine, 2019, v. 22, n. 12, p. 1491, doi. 10.1089/jpm.2019.0330

By:

Yarchoan, Mark;
Tucker, Wendy;
Smith, Thomas J.

Publication type:

Article

Ipilimumab-Induced Enteritis without Colitis: A New Challenge.

Published in:

Case Reports in Oncology, 2016, v. 9, n. 3, p. 705, doi. 10.1159/000452403

By:

Messmer, Marcus;
Upreti, Sunita;
Tarabishy, Yaman;
Mazumder, Nikhilesh;
Chowdhury, Reezwana;
Yarchoan, Mark;
Holdhoff, Matthias

Publication type:

Article

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.

Published in:

British Journal of Cancer, 2018, v. 118, n. 2, p. e2, doi. 10.1038/bjc.2017.418

By:

Shroff, Rachna T;
Yarchoan, Mark;
O'Connor, Ashley;
Gallagher, Denise;
Zahurak, Marianna L;
Rosner, Gary;
Ohaji, Chimela;
Sartorius-Mergenthaler, Susan;
Parkinson, Rose;
Subbiah, Vivek;
Zinner, Ralph;
Azad, Nilofer S

Publication type:

Article

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.

Published in:

2018

By:

Shroff, Rachna T;
Yarchoan, Mark;
O'Connor, Ashley;
Gallagher, Denise;
Zahurak, Marianna L;
Rosner, Gary;
Ohaji, Chimela;
Sartorius-Mergenthaler, Susan;
Parkinson, Rose;
Subbiah, Vivek;
Zinner, Ralph;
Azad, Nilofer S

Publication type:

journal article

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.

Published in:

British Journal of Cancer, 2017, v. 116, n. 11, p. 1402, doi. 10.1038/bjc.2017.119

By:

Shroff, Rachna T;
Yarchoan, Mark;
O'Connor, Ashley;
Gallagher, Denise;
Zahurak, Marianna L;
Rosner, Gary;
Ohaji, Chimela;
Sartorius-Mergenthaler, Susan;
Subbiah, Vivek;
Zinner, Ralph;
Azad, Nilofer S

Publication type:

Article

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.

Published in:

2017

By:

Shroff, Rachna T;
Yarchoan, Mark;
O'Connor, Ashley;
Gallagher, Denise;
Zahurak, Marianna L;
Rosner, Gary;
Ohaji, Chimela;
Sartorius-Mergenthaler, Susan;
Subbiah, Vivek;
Zinner, Ralph;
Azad, Nilofer S

Publication type:

journal article

Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors.

Published in:

American Journal of Hematology, 2019, v. 94, n. 5, p. 563, doi. 10.1002/ajh.25448

By:

Leaf, Rebecca Karp;
Ferreri, Christopher;
Rangachari, Deepa;
Mier, James;
Witteles, Wesley;
Ansstas, George;
Anagnostou, Theodora;
Zubiri, Leyre;
Piotrowska, Zofia;
Oo, Thein H.;
Iberri, David;
Yarchoan, Mark;
Salama, April K. S.;
Johnson, Douglas B.;
Leavitt, Andrew D.;
Rahma, Osama E.;
Reynolds, Kerry L.;
Leaf, David E.

Publication type:

Article

Predicting survival of patients with advanced hepatocellular carcinoma receiving combination targeted immunotherapy: an evaluation of volumetric imaging parameters.

Published in:

Abdominal Radiology, 2024, v. 49, n. 8, p. 2595, doi. 10.1007/s00261-024-04257-0

By:

Mohseni, Alireza;
Baghdadi, Azarakhsh;
Madani, Seyedeh Panid;
Shahbazian, Haneyeh;
Mirza-Aghazadeh-Attari, Mohammad;
Borhani, Ali;
Afyouni, Shadi;
Zandieh, Ghazal;
Baretti, Marina;
Kim, Amy K.;
Yarchoan, Mark;
Kamel, Ihab R.

Publication type:

Article

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer.

Published in:

Cancer Medicine, 2020, v. 9, n. 4, p. 1485, doi. 10.1002/cam4.2763

By:

Yarchoan, Mark;
Huang, Chiung‐Yu;
Zhu, Qingfeng;
Ferguson, Anna K.;
Durham, Jennifer N.;
Anders, Robert A.;
Thompson, Elizabeth D.;
Rozich, Noah S.;
Thomas, Dwayne L.;
Nauroth, Julie M.;
Rodriguez, Christina;
Osipov, Arsen;
De Jesus‐Acosta, Ana;
Le, Dung T.;
Murphy, Adrian G.;
Laheru, Daniel;
Donehower, Ross C.;
Jaffee, Elizabeth M.;
Zheng, Lei;
Azad, Nilofer S.

Publication type:

Article

Opportunities and Challenges for Biosimilars: What's on the Horizon in the Global Insulin Market?

Published in:

Clinical Diabetes, 2012, v. 30, n. 4, p. 138, doi. 10.2337/diaclin.30.4.138

By:

Rotenstein, Lisa S.;
Ran, Nina;
Shivers, Joseph P.;
Yarchoan, Mark;
Close, Kelly L.

Publication type:

Article

The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?

Published in:

2012

By:

Rotenstein, Lisa S.;
Kozak, Benjamin M.;
Shivers, Joseph P.;
Yarchoan, Mark;
Close, John;
Close, Kelly L.

Publication type:

Journal Article

The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?

Published in:

Clinical Diabetes, 2012, v. 30, n. 2, p. 44, doi. 10.2337/diaclin.30.2.44

By:

Rotenstein, Lisa S.;
Kozak, Benjamin M.;
Shivers, Joseph P.;
Yarchoan, Mark;
Close, John;
Close, Kelly L.

Publication type:

Article

MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity.

Published in:

PLoS ONE, 2019, v. 14, n. 10, p. 1, doi. 10.1371/journal.pone.0224600

By:

Yarchoan, Mark;
Mohan, Aditya A.;
Dennison, Lauren;
Vithayathil, Teena;
Ruggieri, Amanda;
Lesinski, Gregory B.;
Armstrong, Todd D.;
Azad, Nilofer S.;
Jaffee, Elizabeth M.

Publication type:

Article

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy.

Published in:

Cancer Informatics, 2022, v. 21, p. 1, doi. 10.1177/11769351221136081

By:

Bigelow, Emma;
Saria, Suchi;
Piening, Brian;
Curti, Brendan;
Dowdell, Alexa;
Weerasinghe, Roshanthi;
Bifulco, Carlo;
Urba, Walter;
Finkelstein, Noam;
Fertig, Elana J;
Baras, Alex;
Zaidi, Neeha;
Jaffee, Elizabeth;
Yarchoan, Mark

Publication type:

Article

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy.

Published in:

Cancer Informatics, 2022, v. 21, p. 1, doi. 10.1177/11769351221136081

By:

Bigelow, Emma;
Saria, Suchi;
Piening, Brian;
Curti, Brendan;
Dowdell, Alexa;
Weerasinghe, Roshanthi;
Bifulco, Carlo;
Urba, Walter;
Finkelstein, Noam;
Fertig, Elana J.;
Baras, Alex;
Zaidi, Neeha;
Jaffee, Elizabeth;
Yarchoan, Mark

Publication type:

Article

Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal Cancer.

Published in:

Current Oncology, 2023, v. 30, n. 1, p. 75, doi. 10.3390/curroncol30010006

By:

Christenson, Eric S.;
Lee, Valerie;
Wang, Hao;
Yarchoan, Mark;
De Jesus-Acosta, Ana;
Azad, Nilo;
Gurakar, Ahmet;
Lin, Ming-Tseh;
Le, Dung T.;
Brennan, Daniel C.;
Jaffee, Elizabeth M.;
Bever, Katherine

Publication type:

Article

Epigenetic modifiers synergize with immune-checkpoint blockade to enhance long-lasting antitumor efficacy.

Published in:

2021

By:

Baretti, Marina;
Yarchoan, Mark

Publication type:

journal article

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma.

Published in:

NPJ Systems Biology & Applications, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41540-019-0107-2

By:

Jafarnejad, Mohammad;
Sové, Richard J.;
Danilova, Ludmila;
Mirando, Adam C.;
Zhang, Yu;
Yarchoan, Mark;
Tran, Phuoc T.;
Pandey, Niranjan B.;
Fertig, Elana J.;
Popel, Aleksander S.

Publication type:

Article

Trends of Clinical Outcomes of Patients with Advanced Hepatocellular Carcinoma Treated with First-Line Sorafenib in Randomized Controlled Trials.

Published in:

Gastrointestinal Tumors, 2022, v. 9, n. 1, p. 19, doi. 10.1159/000521625

By:

Brown, Timothy J.;
Gupta, Arjun;
Sedhom, Ramy;
Beg, Muhammad S.;
Karasic, Thomas B.;
Yarchoan, Mark

Publication type:

Article

Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence.

Published in:

Genome Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13073-023-01218-y

By:

Zhang, Shuming;
Yuan, Long;
Danilova, Ludmila;
Mo, Guanglan;
Zhu, Qingfeng;
Deshpande, Atul;
Bell, Alexander T. F.;
Elisseeff, Jennifer;
Popel, Aleksander S.;
Anders, Robert A.;
Jaffee, Elizabeth M.;
Yarchoan, Mark;
Fertig, Elana J.;
Kagohara, Luciane T.

Publication type:

Article

Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways.

Published in:

Genome Biology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s13059-021-02363-6

By:

Ho, Won Jin;
Erbe, Rossin;
Danilova, Ludmila;
Phyo, Zaw;
Bigelow, Emma;
Stein-O'Brien, Genevieve;
Thomas II, Dwayne L.;
Charmsaz, Soren;
Gross, Nicole;
Woolman, Skylar;
Cruz, Kayla;
Munday, Rebecca M.;
Zaidi, Neeha;
Armstrong, Todd D.;
Sztein, Marcelo B.;
Yarchoan, Mark;
Thompson, Elizabeth D.;
Jaffee, Elizabeth M.;
Fertig, Elana J.

Publication type:

Article

Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.

Published in:

Acta Neuropathologica, 2014, v. 128, n. 5, p. 679, doi. 10.1007/s00401-014-1328-5

By:

Yarchoan, Mark;
Toledo, Jon;
Lee, Edward;
Arvanitakis, Zoe;
Kazi, Hala;
Han, Li-Ying;
Louneva, Natalia;
Lee, Virginia;
Kim, Sangwon;
Trojanowski, John;
Arnold, Steven

Publication type:

Article

Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors.

Published in:

Cancers, 2022, v. 14, n. 21, p. 5347, doi. 10.3390/cancers14215347

By:

Chen, Krista Y.;
Popovic, Aleksandra;
Hsiehchen, David;
Baretti, Marina;
Griffith, Paige;
Bista, Ranjan;
Baghdadi, Azarakhsh;
Kamel, Ihab R.;
Simon, Sanford M.;
Migler, Rachael D.;
Yarchoan, Mark

Publication type:

Article

Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Published in:

Brain: A Journal of Neurology, 2012, v. 135, n. 12, p. 3749, doi. 10.1093/brain/aws271

By:

Yarchoan, Mark;
Xie, Sharon X.;
Kling, Mitchel A.;
Toledo, Jon B.;
Wolk, David A.;
Lee, Edward B.;
Van Deerlin, Vivianna;
Lee, Virginia M.-Y.;
Trojanowski, John Q.;
Arnold, Steven E.

Publication type:

Article

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease.

Published in:

Diabetes, 2014, v. 63, n. 7, p. 2253, doi. 10.2337/db14-0287

By:

Yarchoan, Mark;
Arnold, Steven E.

Publication type:

Article

Rapidly progressive metastatic cholangiocarcinoma in a postpartum patient with cystic fibrosis: a case report.

Published in:

2020

By:

Carson, Sara W.;
Craven, Kelly E.;
Nauen, David;
Montemayor, Kristina;
Yarchoan, Mark;
Burns, William R.;
Merlo, Christian A.;
West, Natalie E.

Publication type:

journal article

Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis.

Published in:

Healthcare (2227-9032), 2023, v. 11, n. 18, p. 2571, doi. 10.3390/healthcare11182571

By:

Gupta, Amol;
Zorzi, Jane;
Ho, Won Jin;
Baretti, Marina;
Azad, Nilofer Saba;
Griffith, Paige;
Dao, Doan;
Kim, Amy;
Philosophe, Benjamin;
Georgiades, Christos;
Kamel, Ihab;
Burkhart, Richard;
Liddell, Robert;
Hong, Kelvin;
Shubert, Christopher;
Lafaro, Kelly;
Meyer, Jeffrey;
Anders, Robert;
Burns III, William;
Yarchoan, Mark

Publication type:

Article

Chronic Losartan Administration Reduces Mortality and Preserves Cardiac but Not Skeletal Muscle Function in Dystrophic Mice.

Published in:

PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0020856

By:

Bish, Lawrence T.;
Yarchoan, Mark;
Sleeper, Meg M.;
Gazzara, Jeffrey A.;
Morine, Kevin J.;
Acosta, Pedro;
Barton, Elisabeth R.;
Sweeney, H. Lee

Publication type:

Article

Tumor and Systemic Immunomodulatory Effects of MEK Inhibition.

Published in:

Current Oncology Reports, 2021, v. 23, n. 2, p. 1, doi. 10.1007/s11912-020-01008-4

By:

Dennison, Lauren;
Mohan, Aditya A.;
Yarchoan, Mark

Publication type:

Article

New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma.

Published in:

Drugs, 2023, v. 83, n. 12, p. 1091, doi. 10.1007/s40265-023-01907-3

By:

Gordan, John D.;
Keenan, Bridget P.;
Lim, Huat Chye;
Yarchoan, Mark;
Kelley, R. Katie

Publication type:

Article

Relationships of cerebrovascular atherosclerosis with amyloid, tau, α-synuclein and TDP-43 pathologies in neurodegenerative disease dementias

Published in:

2012

By:

Yarchoan, Mark;
Xie, Sharon X.;
Kling, Mitchel A.;
Toledo, Juan B.;
Wolk, David A.;
Lee, Edward B.;
Van Deerlin, Vivianna M.;
Virginia, M.-Y. Lee;
Trojanowski, John Q.;
Arnold, Steven E.

Publication type:

Abstract

Relationships of cerebrovascular atherosclerosis with amyloid, tau, α-synuclein and TDP-43 pathologies in neurodegenerative disease dementias.

Published in:

2012

By:

Arnold, Steven;
Yarchoan, Mark;
Xie, Sharon;
Kling, Mitchel;
Toledo, Juan;
Wolk, David;
Lee, Edward;
Van Deerlin, Vivianna;
Lee, Virginia;
Trojanowski, John

Publication type:

Abstract

Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic.

Published in:

2021

By:

Jia, Angela Y.;
Popovic, Aleksandra;
Mohan, Aditya A.;
Zorzi, Jane;
Griffith, Paige;
Kim, Amy K.;
Anders, Robert A.;
Burkhart, Richard A.;
Lafaro, Kelly;
Georgiades, Christos;
Azad, Nilofer S.;
Liddell, Robert P.;
Baretti, Marina;
Kamel, Ihab R.;
Narang, Amol;
Yarchoan, Mark;
Meyer, Jeffrey

Publication type:

journal article

Multi-Scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular Carcinoma.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.892250

By:

Mi, Haoyang;
Ho, Won Jin;
Yarchoan, Mark;
Popel, Aleksander S.

Publication type:

Article